BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 226832)

  • 1. Adipose tissue lipoprotein lipase activity in type III hyperlipoproteinemia.
    Goldberg AP; Applebaum-Bowden DM; Hazzard WR
    Metabolism; 1979 Nov; 28(11):1122-6. PubMed ID: 226832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
    Breier C
    Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).
    Sandholzer C; Feussner G; Brunzell J; Utermann G
    J Clin Invest; 1992 Nov; 90(5):1958-65. PubMed ID: 1430218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertriglyceridaemia associated with an abnormal triglyceride-rich lipoprotein carrying excess apolipoprotein C-III-2.
    Stocks J; Holdsworth G; Galton D
    Lancet; 1979 Sep; 2(8144):667-71. PubMed ID: 90760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: relation to serum lipoproteins.
    Nikkilä EA; Taskinen MR; Rehunen S; Härkönen M
    Metabolism; 1978 Nov; 27(11):1661-7. PubMed ID: 212665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of magnesium deficiency on post-heparin lipase activity and tissue lipoprotein lipase in the rat.
    Rayssiguier Y; Noé L; Etienne J; Gueux E; Cardot P; Mazur A
    Lipids; 1991 Mar; 26(3):182-6. PubMed ID: 2046484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial lipoprotein lipase and apolipoprotein C-II deficiency. Lipoprotein and apoprotein analysis, adipose tissue and hepatic lipoprotein lipase levels in seven patients and their first degree relatives.
    Fellin R; Baggio G; Poli A; Augustin J; Baiocchi MR; Baldo G; Sinigaglia M; Greten H; Crepaldi G
    Atherosclerosis; 1983 Oct; 49(1):55-68. PubMed ID: 6651913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.
    Weinstock PH; Bisgaier CL; Aalto-Setälä K; Radner H; Ramakrishnan R; Levak-Frank S; Essenburg AD; Zechner R; Breslow JL
    J Clin Invest; 1995 Dec; 96(6):2555-68. PubMed ID: 8675619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
    Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
    Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man.
    Nikkilä EA; Taskinen MR; Kekki M
    Atherosclerosis; 1978 Apr; 29(4):497-501. PubMed ID: 208590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein lipase activity in adipose tissue and skeletal muscle of human diabetics during insulin deprivation and restoration.
    Taskinen MR; Nikkilä EA; Nousiainen R; Gordin A
    Scand J Clin Lab Invest; 1981 May; 41(3):263-8. PubMed ID: 7031837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
    Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of adipose tissue lipoprotein lipase by lipoprotein fractions from normals and patients with type v hyperlipoproteinemia.
    Lisch HJ; Patsch W; Riedler L; Sailer S; Braunsteiner H
    Klin Wochenschr; 1978 Nov; 56(21):1067-9. PubMed ID: 213640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary report: treatment of type 3 hyperlipoproteinemia with mevinolin.
    East CA; Grundy SM; Bilheimer DW
    Metabolism; 1986 Feb; 35(2):97-8. PubMed ID: 3633017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein lipase activity of adipose tissue, skeletal muscle and post-heparin plasma in primary endogenous hypertriglyceridaemia: relation to lipoprotein pattern and to obesity.
    Taskinen MR; Nikkilä EA; Kuusi T
    Eur J Clin Invest; 1982 Oct; 12(5):433-8. PubMed ID: 6816616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
    Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC
    Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol in the plasma very low density lipoprotein fraction in patients with type III hyperlipoproteinemia: analysis of factors which modulate its concentration.
    Sutherland WH; Janus ED; Nye ER; Grant S
    Biochem Med Metab Biol; 1988 Jun; 39(3):305-11. PubMed ID: 3165001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of caloric restriction on lipid metabolism in man: changes of tissue lipoprotein lipase activities and of serum lipoproteins.
    Taskinen MR; Nikkilä EA
    Atherosclerosis; 1979 Mar; 32(3):289-99. PubMed ID: 223589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of estrogen therapy on apolipoprotein E in type II hyperlipoproteinemia.
    Falko JM; Schonfeld G; Witztum JL; Kolar J; Weidman SW
    Metabolism; 1979 Nov; 28(11):1171-7. PubMed ID: 226834
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.